tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumCompany AnnouncementsContineum Therapeutics Reports Q2 2025 Results and Clinical Progress
1M ago
Premium
Ratings
Strategic Focus on PIPE-791 Drives Buy Rating for Contineum Therapeutics
1M ago
Contineum reports Q2 EPS (62c), consensus (41c)
Premium
The Fly
Contineum reports Q2 EPS (62c), consensus (41c)
2M ago
Contineum initiated with an Outperform at William Blair
PremiumThe FlyContineum initiated with an Outperform at William Blair
3M ago
Premium
Ratings
Promising Developments at Contineum Therapeutics Signal Undervaluation and Favorable Risk-Reward
4M ago
Premium
Company Announcements
Contineum Therapeutics Reports Q1 2025 Financial Results
4M ago
new option listings on April 9th
PremiumThe Flynew option listings on April 9th
5M ago
Premium
Company Announcements
Contineum Therapeutics Appoints Diego Miralles to Board
6M ago
Premium
Ratings
Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100